Ken Griffin
CDNA icon

Ken Griffin’s CareDx CDNA Stock Holding History

Ken Griffin’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28,600
Closed -$539K – 13083
2025
Q4 		$539K Sell
28,600
-12,700
-31% -$213K ﹤0.01% 8852
2025
Q3 		$601K Buy
41,300
+9,500
+30% +$135K ﹤0.01% 8681
2025
Q2 		$621K Buy
31,800
+16,000
+101% +$284K ﹤0.01% 8122
2025
Q1 		$280K Sell
15,800
-3,900
-20% -$84K ﹤0.01% 9752
2024
Q4 		$422K Sell
19,700
-5,800
-23% -$141K ﹤0.01% 8937
2024
Q3 		$796K Buy
25,500
+1,500
+6% +$37.3K ﹤0.01% 7311
2024
Q2 		$373K Buy
24,000
+14,100
+142% +$170K ﹤0.01% 8666
2024
Q1 		$105K Buy
9,900
+3,400
+52% +$34K ﹤0.01% 11295
2023
Q4 		$78K Sell
6,500
-1,600
-20% -$13.1K ﹤0.01% 11256
2023
Q3 		$56.7K Sell
8,100
-5,900
-42% -$54.5K ﹤0.01% 11604
2023
Q2 		$119K Buy
14,000
+5,100
+57% +$42.5K ﹤0.01% 10669
2023
Q1 		$81.3K Buy
8,900
+5,600
+170% +$71.6K ﹤0.01% 11531
2022
Q4 		$37.7K Sell
3,300
-18,400
-85% -$273K ﹤0.01% 12486
2022
Q3 		$369K Sell
21,700
-1,400
-6% -$30K ﹤0.01% 9121
2022
Q2 		$496K Buy
23,100
+7,100
+44% +$197K ﹤0.01% 8674
2022
Q1 		$592K Sell
16,000
-29,700
-65% -$1.16M ﹤0.01% 8987
2021
Q4 		$2.08M Buy
45,700
+22,600
+98% +$1.18M ﹤0.01% 6144
2021
Q3 		$1.46M Sell
23,100
-7,500
-25% -$571K ﹤0.01% 7142
2021
Q2 		$2.8M Sell
30,600
-9,000
-23% -$715K ﹤0.01% 5768
2021
Q1 		$2.7M Sell
39,600
-17,500
-31% -$1.36M ﹤0.01% 5700
2020
Q4 		$4.14M Sell
57,100
-17,600
-24% -$1.02M ﹤0.01% 3994
2020
Q3 		$2.83M Buy
74,700
+67,600
+952% +$2.28M ﹤0.01% 4080
2020
Q2 		$252K Sell
7,100
-30,800
-81% -$877K ﹤0.01% 8197
2020
Q1 		$827K Sell
37,900
-4,100
-10% -$91.9K ﹤0.01% 5662
2019
Q4 		$906K Buy
42,000
+28,000
+200% +$642K ﹤0.01% 5779
2019
Q3 		$317K Sell
14,000
-9,700
-41% -$269K ﹤0.01% 7468
2019
Q2 		$853K Buy
+23,700
New +$759K ﹤0.01% 5955

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Ken Griffin's CDNA Position: Q1 2026 in Review

Ken Griffin reduced its CareDx (CDNA) stake by 87% in Q1 2026, selling an estimated $10.6M and leaving 84,173 shares worth $1.46M. The position accounts for ﹤0.01% of the portfolio, ranked #6773.

Ken Griffin first reported a position in CDNA in Q1 2018 and has held it in 30 quarters since. The position peaked at $24.7M in Q3 2021. 190 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.

  • Ken Griffin held 84,173 shares of CareDx worth $1.46M as of Q1 2026.
  • Ken Griffin sold 558,589 CareDx shares in Q1 2026, an estimated $10.6M.
  • CareDx made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #6773 holding.
  • Ken Griffin first reported a position in CareDx in Q1 2018 and has held it in 30 quarters since.
  • Ken Griffin's CareDx position peaked at $24.7M in Q3 2021.
  • 190 funds tracked by Wall St. Rank held CareDx as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.